Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)-Reference-Cited by-同舟云学术

Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)

Published:2016-06-22 Issue:8 Volume:8 Page:1593-1607
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Fiorillo Marco¹²³,Lamb Rebecca¹²,Tanowitz Herbert B.⁴,Cappello Anna Rita³,Martinez-Outschoorn Ubaldo E.⁵,Sotgia Federica⁶,Lisanti Michael P.¹²

Affiliation:

1. The Breast Cancer Now Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK

2. The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK

3. The Department of Pharmacy, Health and Nutritional Sciences, The University of Calabria, Cosenza, Italy

4. Departments of Pathology and Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA

5. The Sidney Kimmel Cancer Center, Philadelphia, PA 19107, USA

6. School of Environment & Life Sciences, Cockcroft Building, University of Salford, Salford, UK

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial bioenergetics of breast cancer;Mitochondrion;2024-11

2. Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies;Signal Transduction and Targeted Therapy;2024-08-14

3. Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment;Cancer Communications;2024-07-12

4. Drug repurposing: a retrospective revolution in breast cancer medicine;Discover Medicine;2024-07-12

5. Metabolic vulnerability of cancer stem cells and their niche;Frontiers in Pharmacology;2024-04-10